221 related articles for article (PubMed ID: 18250965)
1. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma in elderly patients.
Minniti G; De Sanctis V; Muni R; Filippone F; Bozzao A; Valeriani M; Osti MF; De Paula U; Lanzetta G; Tombolini V; Maurizi Enrici R
J Neurooncol; 2008 May; 88(1):97-103. PubMed ID: 18250965
[TBL] [Abstract][Full Text] [Related]
2. Treatment options and outcomes for glioblastoma in the elderly patient.
Arvold ND; Reardon DA
Clin Interv Aging; 2014; 9():357-67. PubMed ID: 24591820
[TBL] [Abstract][Full Text] [Related]
3. Prolonged Temozolomide Maintenance Therapy in Newly Diagnosed Glioblastoma.
Skardelly M; Dangel E; Gohde J; Noell S; Behling F; Lepski G; Borchers C; Koch M; Schittenhelm J; Bisdas S; Naumann A; Paulsen F; Zips D; von Hehn U; Ritz R; Tatagiba MS; Tabatabai G
Oncologist; 2017 May; 22(5):570-575. PubMed ID: 28360216
[TBL] [Abstract][Full Text] [Related]
4. Phase 1/2 Trial of 5-Fraction Stereotactic Radiosurgery With 5-mm Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Health-Related Quality of Life Results.
Pollom EL; Fujimoto D; Wynne J; Seiger K; Modlin LA; Jacobs LR; Azoulay M; von Eyben R; Tupper L; Gibbs IC; Hancock SL; Li G; Chang SD; Adler JR; Harsh GR; Harraher C; Nagpal S; Thomas RP; Recht LD; Choi CYH; Soltys SG
Int J Radiat Oncol Biol Phys; 2017 May; 98(1):123-130. PubMed ID: 28586949
[TBL] [Abstract][Full Text] [Related]
5. A survival analysis of GBM patients in the West of Scotland pre- and post-introduction of the Stupp regime.
Teo M; Martin S; Owusu-Agyemang K; Nowicki S; Clark B; Mackinnon M; Stewart W; Paul J; St George J
Br J Neurosurg; 2014 Jun; 28(3):351-5. PubMed ID: 24111708
[TBL] [Abstract][Full Text] [Related]
6. A combined analysis of two prospective randomised studies exploring the impact of extended post-radiation temozolomide on survival outcomes in newly diagnosed glioblastoma.
Gately L; Mesía C; Sepúlveda JM; Del Barco S; Pineda E; Gironés R; Fuster J; Hong W; Dumas M; Gill S; Navarro LM; Herrero A; Dowling A; de Las Peñas R; Vaz MA; Alonso M; Lwin Z; Harrup R; Peralta S; Long A; Perez-Segura P; Ahern E; Garate CO; Wong M; Campbell R; Cuff K; Jennens R; Gallego O; Underhill C; Martinez-Garcia M; Covela M; Cooper A; Brown S; Rosenthal M; Torres J; Collins IM; Gibbs P; Balana C
J Neurooncol; 2024 Feb; 166(3):407-415. PubMed ID: 38153582
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of anlotinib combined with the STUPP regimen in patients with newly diagnosed glioblastoma: a multicenter, single-arm, phase II trial.
Lai S; Li P; Liu X; Liu G; Xie T; Zhang X; Wang X; Huang J; Tang Y; Liu Z; Shen G; Li C; Lu F; Wang L; Jiang F; Sun C; Chen Y; Chen M
Cancer Biol Med; 2024 Mar; 21(5):433-44. PubMed ID: 38445445
[TBL] [Abstract][Full Text] [Related]
8. Wilms tumor 1 peptide vaccination combined with temozolomide against newly diagnosed glioblastoma: safety and impact on immunological response.
Hashimoto N; Tsuboi A; Kagawa N; Chiba Y; Izumoto S; Kinoshita M; Kijima N; Oka Y; Morimoto S; Nakajima H; Morita S; Sakamoto J; Nishida S; Hosen N; Oji Y; Arita N; Yoshimine T; Sugiyama H
Cancer Immunol Immunother; 2015 Jun; 64(6):707-16. PubMed ID: 25772149
[TBL] [Abstract][Full Text] [Related]
9. Treatment of very elderly glioblastoma patients ≥ 75 years of age: whom to treat.
Baumgarten P; Prange G; Kamp MA; Monden D; Neef V; Schwarzer F; Dubinski D; Dinc N; Weber KJ; Czabanka M; Hattingen E; Ronellenfitsch MW; Steinbach JP; Senft C
J Neurooncol; 2023 Dec; 165(3):509-515. PubMed ID: 38032426
[TBL] [Abstract][Full Text] [Related]
10. Letter to the editor regarding "The efficacy and safety of radiotherapy with adjuvant temozolomide for glioblastoma: A meta-analysis of randomized controlled studies".
Yang L; Ye Z; Huang Q
Clin Neurol Neurosurg; 2023 Apr; 227():107666. PubMed ID: 36870087
[No Abstract] [Full Text] [Related]
11. Zotiraciclib (TG02) for newly diagnosed glioblastoma in the elderly or for recurrent glioblastoma: The EORTC 1608 STEAM trial.
Le Rhun E; Gorlia T; Felsberg J; Jongen J; Maurage CA; Ducray F; Gramatzki D; Hau P; Chinot OL; Preusser M; Cartalat S; Roth P; van den Bent M; Furtner J; Collienne M; Reifenberger G; Weller M
Eur J Cancer; 2024 Feb; 198():113475. PubMed ID: 38159337
[TBL] [Abstract][Full Text] [Related]
12. Treatment of glioblastoma in Greenlandic patients.
Frandsen S; Pedersen AJ; Gredal O; Møller S; Geissler UW; Nørøxe DS
Int J Circumpolar Health; 2023 Dec; 82(1):2285077. PubMed ID: 37992407
[TBL] [Abstract][Full Text] [Related]
13. The Assessment of Clinical Outcomes and Prognostic Factors in Glioblastoma Patients.
Demircan NV; Erpolat OP; Guzel C; Senturk E; Bora H; Karahacioglu E
Turk Neurosurg; 2023; 33(5):870-886. PubMed ID: 37528719
[TBL] [Abstract][Full Text] [Related]
14. Comparative study of concurrent conventional chemoradiotherapy versus hypofractionated chemoradiotherapy in newly diagnosed glioblastoma multiforme postoperative patients.
Khatri NK; Kumar HS; Sharma N; Jakhar SL; Dhaka S
J Cancer Res Ther; 2023; 19(5):1126-1130. PubMed ID: 37787273
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of Temozolomide in a Patient With Glioblastoma Undergoing Hemodialysis: A Short Communication.
Tanaka F; Irie K; Fukui N; Horii R; Imamura H; Hirabatake M; Ikesue H; Muroi N; Fukushima S; Sakai N; Hashida T
Ther Drug Monit; 2023 Dec; 45(6):823-826. PubMed ID: 37646650
[TBL] [Abstract][Full Text] [Related]
16. Radiotherapy-drug combinations in the treatment of glioblastoma: a brief review.
McAleavey PG; Walls GM; Chalmers AJ
CNS Oncol; 2022 Jun; 11(2):CNS86. PubMed ID: 35603818
[TBL] [Abstract][Full Text] [Related]
17. Prognosis of glioblastoma patients improves significantly over time interrogating historical controls.
Thomas-Joulié A; Tran S; El Houari L; Seyve A; Bielle F; Birzu C; Lozano-Sanchez F; Mokhtari K; Giry M; Marie Y; Laigle-Donadey F; Dehais C; Houillier C; Psimaras D; Alentorn A; Laurenge A; Touat M; Sanson M; Hoang-Xuan K; Kas A; Rozenblum L; Habert MO; Nichelli L; Leclercq D; Galanaud D; Jacob J; Karachi C; Capelle L; Carpentier A; Mathon B; Belin L; Idbaih A
Eur J Cancer; 2024 May; 202():114004. PubMed ID: 38493668
[TBL] [Abstract][Full Text] [Related]
18. Extended dosing (12 cycles) vs conventional dosing (6 cycles) of adjuvant temozolomide in adults with newly diagnosed high-grade gliomas: a randomized, single-blind, two-arm, parallel-group controlled trial.
Anvari K; Seilanian Toussi M; Saghafi M; Javadinia SA; Saghafi H; Welsh JS
Front Oncol; 2024; 14():1357789. PubMed ID: 38774410
[TBL] [Abstract][Full Text] [Related]
19. Exploring management and outcomes of elderly patients with glioblastoma using data from two randomised trials (GEINO1401/EX-TEM).
Gately L; Mesía C; Sepúlveda JM; Del Barco S; Pineda E; Gironés R; Fuster J; Dumas M; Gill S; Navarro LM; Herrero A; Dowling A; de Las Peñas R; Vaz MA; Alonso M; Lwin Z; Harrup R; Peralta S; Long A; Perez-Segura P; Ahern E; Garate CO; Wong M; Campbell R; Cuff K; Jennens R; Gallego O; Underhill C; Martinez-Garcia M; Covela M; Cooper A; Brown S; Rosenthal M; Torres J; Collins IM; Gibbs P; Balana C
J Neurooncol; 2024 Jun; 168(2):299-306. PubMed ID: 38630385
[TBL] [Abstract][Full Text] [Related]
20. Standards of care for treatment of recurrent glioblastoma--are we there yet?
Weller M; Cloughesy T; Perry JR; Wick W
Neuro Oncol; 2013 Jan; 15(1):4-27. PubMed ID: 23136223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
